Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-06

Clinical Trial Update: Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated whether adding Gynostemma pentaphyllum tea to ongoing sulfonylurea therapy improves glycemic control in adults with Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gynostemma pentaphyllum tea
  • Sulfonylureas

Snippet

Sponsor: Hanoi Medical University | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED